These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30073685)

  • 21. The use of feasibility studies for stepped-wedge cluster randomised trials: protocol for a review of impact and scope.
    Kristunas CA; Hemming K; Eborall HC; Gray LJ
    BMJ Open; 2017 Aug; 7(7):e017290. PubMed ID: 28765139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to key recommendations for design and analysis of stepped-wedge cluster randomized trials: A review of trials published 2016-2022.
    Nevins P; Ryan M; Davis-Plourde K; Ouyang Y; Pereira Macedo JA; Meng C; Tong G; Wang X; Ortiz-Reyes L; Caille A; Li F; Taljaard M
    Clin Trials; 2024 Apr; 21(2):199-210. PubMed ID: 37990575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Power analyses for stepped wedge designs with multivariate continuous outcomes.
    Davis-Plourde K; Taljaard M; Li F
    Stat Med; 2023 Feb; 42(4):559-578. PubMed ID: 36565050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size calculation for stepped-wedge cluster-randomized trials with more than two levels of clustering.
    Teerenstra S; Taljaard M; Haenen A; Huis A; Atsma F; Rodwell L; Hulscher M
    Clin Trials; 2019 Jun; 16(3):225-236. PubMed ID: 31018678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stepped wedge designs could reduce the required sample size in cluster randomized trials.
    Woertman W; de Hoop E; Moerbeek M; Zuidema SU; Gerritsen DL; Teerenstra S
    J Clin Epidemiol; 2013 Jul; 66(7):752-8. PubMed ID: 23523551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cluster randomized trial designs for modeling time-varying intervention effects.
    Lee KM; Cheung YB
    Stat Med; 2024 Jan; 43(1):49-60. PubMed ID: 37947024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size calculators for planning stepped-wedge cluster randomized trials: a review and comparison.
    Ouyang Y; Li F; Preisser JS; Taljaard M
    Int J Epidemiol; 2022 Dec; 51(6):2000-2013. PubMed ID: 35679584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of stepped-wedge trial reporting can be reliably assessed using an updated CONSORT: crowd-sourcing systematic review.
    Hemming K; Carroll K; Thompson J; Forbes A; Taljaard M;
    J Clin Epidemiol; 2019 Mar; 107():77-88. PubMed ID: 30500405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintaining the validity of inference from linear mixed models in stepped-wedge cluster randomized trials under misspecified random-effects structures.
    Ouyang Y; Taljaard M; Forbes AB; Li F
    Stat Methods Med Res; 2024 May; ():9622802241248382. PubMed ID: 38807552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inclusion of unexposed clusters improves the precision of fixed effects analysis of stepped-wedge cluster randomized trials.
    Lee KM; Ma X; Yang GM; Cheung YB
    Stat Med; 2022 Jul; 41(15):2923-2938. PubMed ID: 35352382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Group sequential designs for stepped-wedge cluster randomised trials.
    Grayling MJ; Wason JM; Mander AP
    Clin Trials; 2017 Oct; 14(5):507-517. PubMed ID: 28653550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review finds major deficiencies in sample size methodology and reporting for stepped-wedge cluster randomised trials.
    Martin J; Taljaard M; Girling A; Hemming K
    BMJ Open; 2016 Feb; 6(2):e010166. PubMed ID: 26846897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample size determination for stepped wedge cluster randomized trials in pragmatic settings.
    Wang J; Cao J; Zhang S; Ahn C
    Stat Methods Med Res; 2021 Jul; 30(7):1609-1623. PubMed ID: 34139916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
    Zhan D; Ouyang Y; Xu L; Wong H
    Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. power swgee: GEE-based power calculations in stepped wedge cluster randomized trials.
    Gallis JA; Wang X; Rathouz PJ; Preisser JS; Li F; Turner EL
    Stata J; 2022 Dec; 22(4):811-841. PubMed ID: 36968149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The unrecognized role of fidelity in effectiveness-implementation hybrid trials: simulation study and guidance for implementation researchers.
    Trutschel D; Blatter C; Simon M; Holle D; Reuther S; Brunkert T
    BMC Med Res Methodol; 2023 May; 23(1):116. PubMed ID: 37179343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recruitment and implementation challenges were common in stepped-wedge cluster randomized trials: Results from a methodological review.
    Caille A; Taljaard M; Le Vilain-Abraham F; Le Moigne A; Copas AJ; Tubach F; Dechartres A
    J Clin Epidemiol; 2022 Aug; 148():93-103. PubMed ID: 35483552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size determination for GEE analyses of stepped wedge cluster randomized trials.
    Li F; Turner EL; Preisser JS
    Biometrics; 2018 Dec; 74(4):1450-1458. PubMed ID: 29921006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blinded continuous monitoring in clinical trials with recurrent event endpoints.
    Friede T; Häring DA; Schmidli H
    Pharm Stat; 2019 Jan; 18(1):54-64. PubMed ID: 30345693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample size considerations for stepped wedge designs with subclusters.
    Davis-Plourde K; Taljaard M; Li F
    Biometrics; 2023 Mar; 79(1):98-112. PubMed ID: 34719017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.